Spero Therapeutics (SPRO) Return on Capital Employed Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -494.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -649.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4,853.00 |
| 10 | Spero Therapeutics | 154.37 Mn | 98.24 Mn | - | 4,944.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,944.00 |
| Dec 31, 2025 | 6,842.00 |
| Sep 30, 2025 | 8,614.00 |
| Jun 30, 2025 | 621.00 |
| Mar 31, 2025 | -904.00 |
| Dec 31, 2024 | -4,121.00 |
| Sep 30, 2024 | 7,201.00 |
| Jun 30, 2024 | 8,104.00 |
| Mar 31, 2024 | 7,718.00 |
| Dec 31, 2023 | 7,976.00 |
| Sep 30, 2023 | 7,562.00 |
| Jun 30, 2023 | 8,694.00 |
| Mar 31, 2023 | 6,789.00 |
| Dec 31, 2022 | 2,006.00 |
| Sep 30, 2022 | -15,234.00 |
| Jun 30, 2022 | -8,160.00 |
| Mar 31, 2022 | -7,932.00 |
| Dec 31, 2021 | -2,759.00 |
| Sep 30, 2021 | -2,040.00 |
| Jun 30, 2021 | -10.00 |
| Mar 31, 2021 | -273.00 |
| Dec 31, 2020 | 2,062.00 |